Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 28, 2019 - Issue 6
Submit an article Journal homepage
374
Views
8
CrossRef citations to date
0
Altmetric
Editorial

Future directions in endometriosis treatment: discovery and development of novel inhibitors of estrogen biosynthesis

Fabio BarraAcademic Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy;Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, GenoaItalyCorrespondence[email protected]
View further author information
,
Andrea RomanoDepartment of Gynaecology and Obstetrics, GROW - School for Oncology & Developmental Biology, Maastricht University, Maastricht, the NetherlandsView further author information
,
Giovanni GrandiDepartment of Obstetrics, Gynecology and Pediatrics, Obstetrics and Gynecology Unit, Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia, Modena, ItalyView further author information
,
Fabio FacchinettiDepartment of Obstetrics, Gynecology and Pediatrics, Obstetrics and Gynecology Unit, Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia, Modena, ItalyView further author information
&
Simone FerreroAcademic Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy;Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, GenoaItalyView further author information
Pages 501-504 | Received 06 Mar 2019, Accepted 09 May 2019, Published online: 17 May 2019

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sara Clemenza, Silvia Vannuccini, Agostino Ruotolo, Tommaso Capezzuoli & Felice Petraglia. (2022) Advances in targeting estrogen synthesis and receptors in patients with endometriosis. Expert Opinion on Investigational Drugs 31:11, pages 1227-1238.
Read now
Simone Garzon, Antonio Simone Laganà, Fabio Barra, Jvan Casarin, Antonella Cromi, Ricciarda Raffaelli, Stefano Uccella, Massimo Franchi, Fabio Ghezzi & Simone Ferrero. (2020) Aromatase inhibitors for the treatment of endometriosis: a systematic review about efficacy, safety and early clinical development. Expert Opinion on Investigational Drugs 29:12, pages 1377-1388.
Read now

Articles from other publishers (6)

Cristina Volpini, Nora Bloise, Mattia Dominoni, Fabio Barra, Valerio Gaetano Vellone, Paolo Minzioni, Barbara Gardella, Simone Ferrero & Livia Visai. (2023) The nano-revolution in the diagnosis and treatment of endometriosis. Nanoscale 15:43, pages 17313-17325.
Crossref
Katiane de Almeida Da Costa, Helena Malvezzi, Cristine Dobo, Rosa Maria Neme, Renée Zon Filippi, Thiago Pinheiro Arrais Aloia, Elisa Rampazo Prado, Juliana Meola & Carla de Azevedo Piccinato. (2022) Site-Specific Regulation of Sulfatase and Aromatase Pathways for Estrogen Production in Endometriosis. Frontiers in Molecular Biosciences 9.
Crossref
Fabio Barra, Giulio Evangelisti, Carolina Scala & Simone Ferrero. 2022. Immunology of Endometriosis. Immunology of Endometriosis 155 168 .
V. I. Kobylyansky. (2021) Mucociliary apparatus of the fallopian tubes and related pathogenetic aspects contributing to infertility and prospects for correction (analytical review). Obstetrics, Gynecology and Reproduction 15:5, pages 586-598.
Crossref
V.I. Kobylyansky. (2021) Transport function of the fallopian tubes, its structure, mechanisms and role in the female reproductive system (literature review). Problemy reproduktsii 27:1, pages 13.
Crossref
Michal Ciebiera, Salvatore G. Vitale, Simone Ferrero, George A. Vilos, Fabio Barra, Salvatore Caruso, Antonio S. Laganà, Antoni Sierant, Antonio Cianci & Grzegorz Jakiel. (2020) Vilaprisan, a New Selective Progesterone Receptor Modulator in Uterine Fibroid Pharmacotherapy-Will it Really be a Breakthrough?. Current Pharmaceutical Design 26:3, pages 300-309.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.